Skip to content

Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David

Regional, Multicentric Registry of Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05515848
Acronym
AORTLANTIC
Enrollment
529
Registered
2022-08-25
Start date
2021-11-07
Completion date
2023-07-31
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Regurgitation, Aortic Root Aneurysm

Keywords

Valve-sparing aortic root replacement, David procedure, Acute aortic dissection, Aortic Regurgitation, Bicuspid aortic valve, French multicentric registry

Brief summary

Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at six centers (Nantes - Rennes - Brest - Angers - Tours \[two centers\]). The main objective of this study is to evaluate the survival without re-intervention for aortic valve dysfunction (surgery or TAVI).

Detailed description

Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David. Inclusion criteria: Patients undergoing aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at one of the six centers: Nantes, Rennes, Brest, Angers, Tours (two centers). Non-inclusion criteria: Prosthetic replacement of the aortic valve intraoperatively during the first operation. Objectives and endpoints : * The survival without re-intervention for aortic valve dysfunction (surgery or TAVI) * The overall cardiovascular survival * The survival without aortic insufficiency of grade equal to or greater than two * The survival without aortic infective endocarditis * Assessment of long-term stroke risk Assessment of the risk of a major bleeding event in the long term Data analysis : The AORTLANTIC study is included in the EPICARD registry which is the official, national database of the French Society of Cardiac Surgery. Study data will then be collected using EPICARD's electronic Case Report Form (eCRF) and then analyzed using a multivariate Cox model. For the follow-up, the WEPI eCRF is used.

Interventions

OTHERNo intervention

There is no intervention in this retrospective study.

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2021, at one of the six centers: Nantes, Rennes, Brest, Angers,Tours UH. Non inclusion criteria : * Prosthetic replacement of the aortic valve intraoperatively during the first operation.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the survival without re-intervention for aortic valve dysfunction (surgery or TAVI), after aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone DavidConditional survival starting at 30 daysNumber of patients alive without re-intervention for aortic valve dysfunction (surgery or TAVI)

Secondary

MeasureTime frameDescription
Evaluate the overall cardiovascular survival resultsup to 17 monthsNumber of patients alive
Evaluate the absence of aortic insufficiency greater than or equal to grade two between the two types of aortic tube graft (right prosthesis or Valsalva prosthesis)up to 17 monthsNumber of patients alive without aortic insufficiency of grade equal to or greater than two
Evaluate the risk of infective endocarditisup to 17 monthsNumber of patients alive without aortic infective endocarditis
Evaluate the risk of strokeup to 17 monthsNumber of patients alive without stroke
Evaluate the risk of major bleeding eventup to 17 monthsNumber of patients alive major bleeding event

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026